| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0916 |
| Trial ID | ChiCTR2100043093 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Feasibility study of autologous CAR T (targeted BCMA derived from humans) cell immunotherapy for refractory/relapsed multiple myeloma |
| Year | 2021 |
| Country | China |
| Company sponsor | Shaanxi People's Hospital |
| Cohort 1 | |||||||
|
|||||||